# Vectorcardiography in CRT: What We Know and What There Is to Learn

## TL;DR

This paper reviews how vectorcardiography (VCG) can improve cardiac resynchronization therapy (CRT) by providing more detailed heart electrical data than traditional ECG.

## Contribution

The paper offers a comprehensive review of VCG's potential to enhance CRT outcomes and identifies gaps in current evidence.

## Key findings

- VCG provides supplementary electrophysiological data compared to traditional ECG.
- VCG may help optimize CRT by better understanding heart activation patterns.
- Current evidence gaps hinder widespread adoption of VCG in CRT practice.

## Abstract

Vectorcardiography (VCG) is an electrophysiological investigation technique, giving supplementary information about the electrical activation of the heart, compared to traditional 12-lead electrocardiography (ECG). Whereas the 12-lead ECG has found its way into global clinical cardiology practice in numerous cardiac pathophysiological instances, VCG has not. In an investigation of the electrical activation of the heart in cardiac resynchronization therapy (CRT), in order to understand the baseline pathology in potentially eligible patients, and to understand and optimize CRT-derived paced activation of the heart in the therapy’s recipients, all of these aspects are essential to the success of the therapy. Due to a consistently present group of non-responders in CRT, VCG has gained interest as a potential improvement in this field. This review comprehensively summarizes the contemporary evidence for the additional value of VCG in CRT, as well as current deficiencies in evidence, to support its implementation in global practice in addition to, or as a substitution for, traditional 12-lead ECG.